Sachs J, Malaney P, 2002. The economic and social burden of malaria. Nature 415 :680–685.
Mendis K, Sina BJ, Marchesini P, Carter R, 2001. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64 :97–106.
Herrera S, Perlaza BL, Bonelo A, Arevalo-Herrera M, 2002. Aotus monkeys: their great value for anti-malaria vaccines and drug testing. Int J Parasitol 32 :1625–1635.
Collins WE, Warren M, Contacos PG, Skinner JC, Richardson BB, Kearse TS, 1980. The Chesson strain of Plasmodium vivax in Aotus monkeys and anopheline mosquitoes. J Parasitol 66 :488–497.
Sullivan JS, Morris CL, Richardson BB, Galland GG, Jennings VM, Kendall J, Collins WE, 1999. Adaptation of the AMRU-1 strain of Plasmodium vivax to Aotus and Saimiri monkeys and to four species of anopheline mosquitoes. J Parasitol 85 :672–677.
Stewart VA, 2003. Plasmodium vivax under the microscope: the Aotus model. Trends Parasitol 19 :589–594.
Collins WE, Skinner JC, Pappaioanou M, Broderson JR, Ma NS, Filipski V, Stanfill PS, Rogers L, 1988. Infection of Peruvian Aotus nancymai monkeys with different strains of Plasmodium falciparum, P. vivax, and P. malariae. J Parasitol 74 :392–398.
Collins WE, Skinner JC, Pappaioanou M, Ma NS, Broderson JR, Sutton BB, Stanfill PS, 1987. Infection of Aotus vociferans (karyotype V) monkeys with different strains of Plasmodium vivax. J Parasitol 73 :536–540.
Schmidt LH, 1978. Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus). I. The courses of untreated infections. Am J Trop Med Hyg 27 :671–702.
Herrera S, Herrera MA, Perlaza BL, Burki Y, Caspers P, Dobeli H, Rotmann D, Certa U, 1990. Immunization of Aotus monkeys with Plasmodium falciparum blood-stage recombinant proteins. Proc Natl Acad Sci USA 87 :4017–4021.
Herrera S, Herrera MA, Certa U, Corredor A, Guerrero R, 1992. Efficiency of human Plasmodium falciparum malaria vaccine candidates in Aotus lemurinus monkeys. Mem Inst Oswaldo Cruz 87 (Suppl 3):423–428.
Collins WE, 1994. The owl monkey as a model for malaria. Baer JF, Weller RE, Kakoma I, eds. Aotus: The Owl Monkey. San Diego, CA: Academic Press, 217–244.
Nayar JK, Baker RH, Knight JW, Sullivan JS, Morris CL, Richardson BB, Galland GG, Collins WE, 1997. Studies on a primaquine-tolerant strain of Plasmodium vivax from Brazil in Aotus and Saimiri monkeys. J Parasitol 83 :739–745.
Obaldia N III, Rossan RN, Cooper RD, Kyle DE, Nuzum EO, Rieckmann KH, Shanks GD, 1997. WR 238605, chloroquine, and their combinations as blood schizonticides against a chloroquine-resistant strain of Plasmodium vivax in Aotus monkeys. Am J Trop Med Hyg 56 :508–510.
Collins WE, Morris CL, Richardson BB, Sullivan JS, Galland GG, 1994. Further studies on the sporozoite transmission of the Salvador I strain of Plasmodium vivax. J Parasitol 80 :512–517.
Hurtado S, Salas ML, Romero JF, Zapata JC, Ortiz H, Arevalo-Herrera M, Herrera S, 1997. Regular production of infective sporozoites of Plasmodium falciparum and P. vivax in laboratory-bred Anopheles albimanus. Ann Trop Med Parasitol 91 :49–60.
Baer JF, 1994. Husbandry and Medical Management of the Owl Monkey. Baer JF, Weller RE, Kakoma I, eds. Aotus: The Owl Monkey. San Diego, CA: Academic Press, 133–164.
Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario VE, Thaithong S, Brown KN, 1993. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol 61 :315–320.
Sachdeva S, Ahmad G, Malhotra P, Mukherjee P, Chauhan VS, 2004. Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli. Infect Immun 72 :5775–5782.
Kongkasuriyachai D, Bartels-Andrews L, Stowers A, Collins WE, Sullivan J, Sattabongkot J, Torii M, Tsuboi T, Kumar N, 2004. Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28-evaluation of homologous and heterologous antigen-delivery prime-boost strategy. Vaccine 22 :3205–3213.
Ballou WR, Arevalo-Herrera M, Carucci D, Richie TL, Corradin G, Diggs C, Druilhe P, Giersing BK, Saul A, Heppner DG, Kester KE, Lanar DE, Lyon J, Hill AV, Pan W, Cohen JD, 2004. Update on the clinical development of candidate malaria vaccines. Am J Trop Med Hyg 71 :239–247.
Arevalo-Herrera M, Herrera S, 2001. Plasmodium vivax malaria vaccine development. Mol Immunol 38 :443–455.
Leisewitz AL, Rockett KA, Gumede B, Jones M, Urban B, Kwiatkowski DP, 2004. Response of the splenic dendritic cell population to malaria infection. Infect Immun 72 :4233–4239.
Achtman AH, Khan M, MacLennan IC, Langhorne J, 2003. Plasmodium chabaudi infection in mice induces strong B cell responses and striking but temporary changes in splenic cell distribution. J Immunol 171 :317–324.
Collins WE, 1990. Testing of Plasmodium vivax CS proteins in Saimiri monkeys. Bull World Health Organ 68 (Suppl):42–46.
Collins WE, Lobel HO, McClure H, Strobert E, Galland GG, Taylor F, Barreto AL, Roberto RR, Skinner JC, Adams S, Morris CL, 1994. The China I/CDC strain of Plasmodium malariae in Aotus monkeys and chimpanzees. Am J Trop Med Hyg 50 :28–32.
Collins WE, 1992. South American monkeys in the development and testing of malarial vaccines–a review. Mem Inst Oswaldo Cruz 87 (Suppl 3):401–406.
Collins WE, Nguyen-Dinh P, Sullivan JS, Morris CL, Galland GG, Richardson BB, Nesby S, 1998. Adaptation of a strain of Plasmodium vivax from Mauritania to New World monkeys and anopheline mosquitoes. J Parasitol 84 :619–621.
Shute PG, Lupascu G, Branzei P, Maryon M, Constantinescu P, Bruce-Chwatt LJ, Draper CC, Killick-Kendrick R, Garnham PC, 1977. A strain of Plasmodium vivax characterized by prolonged incubation: the effect of numbers of sporozoites on the length of the prepatent period. Trans R Soc Trop Med Hyg 70 :474–481.
Collins WE, Warren M, Skinner JC, Chin W, Richardson BB, 1977. Studies on the Santa Lucia (El Salvador) strain of Plasmodium falciparum in Aotus trivirgatus monkeys. J Parasitol 63 :52–56.
Collins WE, Skinner JC, Pappaioanou M, Broderson JR, Filipski VK, McClure HM, Strobert E, Sutton BB, Stanfill PS, Huong AY, 1988. Sporozoite-induced infections of the Salvador I strain of Plasmodium vivax in Saimiri sciureus boliviensis monkeys. J Parasitol 74 :582–585.
Druihle P, Reina L, Fidock DA, 1998. Immunity to liver stages. Sherman IW, ed. Malaria: Parasite Biology, Pathogenesis, and Protection. Washington, DC: American Society for Microbiology Press, 513–543.
Collins WE, Sullivan JS, Morris CL, Galland GG, Richardson BB, 1996. Observations on the biological nature of Plasmodium vivax sporozoites. J Parasitol 82 :216–219.
Zapata JC, Perlaza BL, Hurtado S, Quintero GE, Jurado D, Gonzalez I, Druilhe P, Arevalo-Herrera M, Herrera S, 2002. Reproducible infection of intact Aotus lemurinus griseimembra monkeys by Plasmodium falciparum sporozoite inoculation. J Parasitol 88 :723–729.
Carrasquilla G, Banguero M, Sanchez P, Carvajal F, Barker RH Jr, Gervais GW, Algarin E, Serrano AE, 2000. Epidemiologic tools for malaria surveillance in an urban setting of low endemicity along the Colombian Pacific coast. Am J Trop Med Hyg 62 :132–137.
Laserson KF, Petralanda I, Hamlin DM, Almera R, Fuentes M, Carrasquel A, Barker RH Jr, 1994. Use of the polymerase chain reaction to directly detect malaria parasites in blood samples from the Venezuelan Amazon. Am J Trop Med Hyg 50 :169–180.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 558 | 480 | 244 |
Full Text Views | 405 | 17 | 7 |
PDF Downloads | 88 | 14 | 2 |
This study describes a successful Plasmodium vivax sporozoite infection in Aotus lemurinus griseimembra. Twenty-eight naive or previously infected monkeys, either splenectomized or spleen intact, were inoculated intravenously or subcutaneously with Plasmodium vivax sporozoites of the Salvador I strain or with two wild isolates (VCC-4 and VCC-5; Vivax-Cali-Colombia). The monkeys were successfully infected regardless of the parasite strain, spleen presence, or inoculation route and showed prepatent periods that ranged from 16 to 89 days. Only one monkey inoculated intravenously failed to develop parasitemia. Since immune protection against malaria pre-erythrocytic forms is mediated by both helper and cytolytic T cells that may home in the spleen and P. vivax cultures are not yet available; the use of spleen-intact A. lemurinus griseimembra, susceptible to both adapted and non-adapted strains of P. vivax sporozoites, is a valuable model for evaluation of pre-erythrocytic vaccine candidates.
Sachs J, Malaney P, 2002. The economic and social burden of malaria. Nature 415 :680–685.
Mendis K, Sina BJ, Marchesini P, Carter R, 2001. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64 :97–106.
Herrera S, Perlaza BL, Bonelo A, Arevalo-Herrera M, 2002. Aotus monkeys: their great value for anti-malaria vaccines and drug testing. Int J Parasitol 32 :1625–1635.
Collins WE, Warren M, Contacos PG, Skinner JC, Richardson BB, Kearse TS, 1980. The Chesson strain of Plasmodium vivax in Aotus monkeys and anopheline mosquitoes. J Parasitol 66 :488–497.
Sullivan JS, Morris CL, Richardson BB, Galland GG, Jennings VM, Kendall J, Collins WE, 1999. Adaptation of the AMRU-1 strain of Plasmodium vivax to Aotus and Saimiri monkeys and to four species of anopheline mosquitoes. J Parasitol 85 :672–677.
Stewart VA, 2003. Plasmodium vivax under the microscope: the Aotus model. Trends Parasitol 19 :589–594.
Collins WE, Skinner JC, Pappaioanou M, Broderson JR, Ma NS, Filipski V, Stanfill PS, Rogers L, 1988. Infection of Peruvian Aotus nancymai monkeys with different strains of Plasmodium falciparum, P. vivax, and P. malariae. J Parasitol 74 :392–398.
Collins WE, Skinner JC, Pappaioanou M, Ma NS, Broderson JR, Sutton BB, Stanfill PS, 1987. Infection of Aotus vociferans (karyotype V) monkeys with different strains of Plasmodium vivax. J Parasitol 73 :536–540.
Schmidt LH, 1978. Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus). I. The courses of untreated infections. Am J Trop Med Hyg 27 :671–702.
Herrera S, Herrera MA, Perlaza BL, Burki Y, Caspers P, Dobeli H, Rotmann D, Certa U, 1990. Immunization of Aotus monkeys with Plasmodium falciparum blood-stage recombinant proteins. Proc Natl Acad Sci USA 87 :4017–4021.
Herrera S, Herrera MA, Certa U, Corredor A, Guerrero R, 1992. Efficiency of human Plasmodium falciparum malaria vaccine candidates in Aotus lemurinus monkeys. Mem Inst Oswaldo Cruz 87 (Suppl 3):423–428.
Collins WE, 1994. The owl monkey as a model for malaria. Baer JF, Weller RE, Kakoma I, eds. Aotus: The Owl Monkey. San Diego, CA: Academic Press, 217–244.
Nayar JK, Baker RH, Knight JW, Sullivan JS, Morris CL, Richardson BB, Galland GG, Collins WE, 1997. Studies on a primaquine-tolerant strain of Plasmodium vivax from Brazil in Aotus and Saimiri monkeys. J Parasitol 83 :739–745.
Obaldia N III, Rossan RN, Cooper RD, Kyle DE, Nuzum EO, Rieckmann KH, Shanks GD, 1997. WR 238605, chloroquine, and their combinations as blood schizonticides against a chloroquine-resistant strain of Plasmodium vivax in Aotus monkeys. Am J Trop Med Hyg 56 :508–510.
Collins WE, Morris CL, Richardson BB, Sullivan JS, Galland GG, 1994. Further studies on the sporozoite transmission of the Salvador I strain of Plasmodium vivax. J Parasitol 80 :512–517.
Hurtado S, Salas ML, Romero JF, Zapata JC, Ortiz H, Arevalo-Herrera M, Herrera S, 1997. Regular production of infective sporozoites of Plasmodium falciparum and P. vivax in laboratory-bred Anopheles albimanus. Ann Trop Med Parasitol 91 :49–60.
Baer JF, 1994. Husbandry and Medical Management of the Owl Monkey. Baer JF, Weller RE, Kakoma I, eds. Aotus: The Owl Monkey. San Diego, CA: Academic Press, 133–164.
Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario VE, Thaithong S, Brown KN, 1993. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol 61 :315–320.
Sachdeva S, Ahmad G, Malhotra P, Mukherjee P, Chauhan VS, 2004. Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli. Infect Immun 72 :5775–5782.
Kongkasuriyachai D, Bartels-Andrews L, Stowers A, Collins WE, Sullivan J, Sattabongkot J, Torii M, Tsuboi T, Kumar N, 2004. Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28-evaluation of homologous and heterologous antigen-delivery prime-boost strategy. Vaccine 22 :3205–3213.
Ballou WR, Arevalo-Herrera M, Carucci D, Richie TL, Corradin G, Diggs C, Druilhe P, Giersing BK, Saul A, Heppner DG, Kester KE, Lanar DE, Lyon J, Hill AV, Pan W, Cohen JD, 2004. Update on the clinical development of candidate malaria vaccines. Am J Trop Med Hyg 71 :239–247.
Arevalo-Herrera M, Herrera S, 2001. Plasmodium vivax malaria vaccine development. Mol Immunol 38 :443–455.
Leisewitz AL, Rockett KA, Gumede B, Jones M, Urban B, Kwiatkowski DP, 2004. Response of the splenic dendritic cell population to malaria infection. Infect Immun 72 :4233–4239.
Achtman AH, Khan M, MacLennan IC, Langhorne J, 2003. Plasmodium chabaudi infection in mice induces strong B cell responses and striking but temporary changes in splenic cell distribution. J Immunol 171 :317–324.
Collins WE, 1990. Testing of Plasmodium vivax CS proteins in Saimiri monkeys. Bull World Health Organ 68 (Suppl):42–46.
Collins WE, Lobel HO, McClure H, Strobert E, Galland GG, Taylor F, Barreto AL, Roberto RR, Skinner JC, Adams S, Morris CL, 1994. The China I/CDC strain of Plasmodium malariae in Aotus monkeys and chimpanzees. Am J Trop Med Hyg 50 :28–32.
Collins WE, 1992. South American monkeys in the development and testing of malarial vaccines–a review. Mem Inst Oswaldo Cruz 87 (Suppl 3):401–406.
Collins WE, Nguyen-Dinh P, Sullivan JS, Morris CL, Galland GG, Richardson BB, Nesby S, 1998. Adaptation of a strain of Plasmodium vivax from Mauritania to New World monkeys and anopheline mosquitoes. J Parasitol 84 :619–621.
Shute PG, Lupascu G, Branzei P, Maryon M, Constantinescu P, Bruce-Chwatt LJ, Draper CC, Killick-Kendrick R, Garnham PC, 1977. A strain of Plasmodium vivax characterized by prolonged incubation: the effect of numbers of sporozoites on the length of the prepatent period. Trans R Soc Trop Med Hyg 70 :474–481.
Collins WE, Warren M, Skinner JC, Chin W, Richardson BB, 1977. Studies on the Santa Lucia (El Salvador) strain of Plasmodium falciparum in Aotus trivirgatus monkeys. J Parasitol 63 :52–56.
Collins WE, Skinner JC, Pappaioanou M, Broderson JR, Filipski VK, McClure HM, Strobert E, Sutton BB, Stanfill PS, Huong AY, 1988. Sporozoite-induced infections of the Salvador I strain of Plasmodium vivax in Saimiri sciureus boliviensis monkeys. J Parasitol 74 :582–585.
Druihle P, Reina L, Fidock DA, 1998. Immunity to liver stages. Sherman IW, ed. Malaria: Parasite Biology, Pathogenesis, and Protection. Washington, DC: American Society for Microbiology Press, 513–543.
Collins WE, Sullivan JS, Morris CL, Galland GG, Richardson BB, 1996. Observations on the biological nature of Plasmodium vivax sporozoites. J Parasitol 82 :216–219.
Zapata JC, Perlaza BL, Hurtado S, Quintero GE, Jurado D, Gonzalez I, Druilhe P, Arevalo-Herrera M, Herrera S, 2002. Reproducible infection of intact Aotus lemurinus griseimembra monkeys by Plasmodium falciparum sporozoite inoculation. J Parasitol 88 :723–729.
Carrasquilla G, Banguero M, Sanchez P, Carvajal F, Barker RH Jr, Gervais GW, Algarin E, Serrano AE, 2000. Epidemiologic tools for malaria surveillance in an urban setting of low endemicity along the Colombian Pacific coast. Am J Trop Med Hyg 62 :132–137.
Laserson KF, Petralanda I, Hamlin DM, Almera R, Fuentes M, Carrasquel A, Barker RH Jr, 1994. Use of the polymerase chain reaction to directly detect malaria parasites in blood samples from the Venezuelan Amazon. Am J Trop Med Hyg 50 :169–180.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 558 | 480 | 244 |
Full Text Views | 405 | 17 | 7 |
PDF Downloads | 88 | 14 | 2 |